This listing is one 30 mL bottle of GW-501516 (cardarine) at a labelled 20 mg/mL, or 600 mg of listed compound, as a liquid research solution shipped from within Canada. GW-501516 is a selective PPAR-delta agonist developed in the 1990s by Ligand Pharmaceuticals and GlaxoSmithKline; it is not a SARM.
Product specifications
| Compound | GW-501516 (Cardarine) |
|---|---|
| Also listed as | Cardarine, GW501516, GW1516 |
| Classification | PPAR-delta agonist; not a SARM |
| CAS number | 317318-70-0 |
| Molecular formula | C21H18F3NO3S2 |
| Molar mass | 453.50 g/mol |
| Listed concentration | 20 mg/mL |
| Volume | 30 mL |
| Total listed compound | 600 mg |
| Format | Labelled liquid research solution |
| Raw-material COA | View raw-material testing |
Research background
GW-501516 has been used as a research tool for peroxisome proliferator-activated receptor delta (PPAR-delta) signalling, including small, short-duration human studies of lipid and metabolic markers. Its pharmaceutical development was abandoned in 2007 after long-term animal studies found cancers developing in multiple organs.
Those exploratory human studies were limited in size and duration and do not establish an approved therapy, general safety, or suitability for personal use.
Status in Canada and sport
Health Canada has stated that cardarine (GW501516) is not authorized in Canada for any use. The World Anti-Doping Agency (WADA) prohibits PPAR-delta agonists such as GW1516.
Research use and storage
This product is sold strictly for laboratory research and analytical purposes. It is not intended for human consumption, therapeutic, bodybuilding, athletic or veterinary use, or the diagnosis, treatment or prevention of disease. Canada SARMs does not provide dosage, cycle or administration guidance.
Keep the container sealed, follow the storage information on its label, and record the product name, concentration, raw-material batch and receipt date in your inventory records.
Frequently asked questions
What does this bottle contain?
One labelled 30 mL liquid research solution of GW-501516 (Cardarine) at a listed concentration of 20 mg/mL, or 600 mg of listed compound in total.
What other names is GW-501516 listed under?
GW-501516 also appears in the literature and in other catalogues as Cardarine, GW501516 and GW1516. The CAS number 317318-70-0 identifies the same compound across those names.
Is cardarine authorized by Health Canada?
No. Health Canada has stated that cardarine (GW501516) is not authorized in Canada for any use, and a research-use label does not change that status.




Reviews
There are no reviews yet.